Lifecore Biomedical Inc. (LFCR)
NASDAQ: LFCR
· Real-Time Price · USD
6.98
-0.08 (-1.13%)
At close: Oct 03, 2025, 3:59 PM
6.86
-1.72%
After-hours: Oct 03, 2025, 07:25 PM EDT
-1.13% (1D)
| Bid | 5.22 |
| Market Cap | 261.04M |
| Revenue (ttm) | 128.87M |
| Net Income (ttm) | -38.72M |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -5.5 |
| Forward PE | -9.81 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 8.94 |
| Volume | 200,814 |
| Avg. Volume (20D) | 154,866 |
| Open | 7.10 |
| Previous Close | 7.06 |
| Day's Range | 6.92 - 7.53 |
| 52-Week Range | 4.33 - 8.85 |
| Beta | 0.62 |
| Ex-Dividend Date | n/a |
About LFCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LFCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LFCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLifecore Biomedical Inc. is scheduled to release its earnings on
Oct 14, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-22.32%
Lifecore Biomedical shares are trading lower after...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call TranscriptUniversal Electronics Inc. (UEIC) Q4 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Paul Josephs - President, CEO & Director Ryan D. Lake - EVP & CFO Conference Call Part...
